Companies Cryptocurrencies
TherapeuticsMD Inc
TherapeuticsMD Inc
Exchange: Nasdaq Global Select
IPO Date: 31/01/2001
CEO: Mr. Robert Finizio
Drug Manufacturers General Specialty & Generic Healthcare 🔗
  • TXMD
  • 9.96
  • 87749792
    market cap
  • 0.01000023
If you bought

shares of TherapeuticsMD Inc (TXMD) on
You would have made
Old Price $12 Current Price $12

TherapeuticsMD, Inc. is a pharmaceutical company, which focuses on developing and commercializing products for women. The company is headquartered in Boca Raton, Florida and currently employs 241 full-time employees. The firm is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. With its SYMBODA technology, it is developing hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through dosage forms and administration routes. Its product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.

Address: 951 W Yamato Rd Ste 220 Boca Raton FLORIDA 33431

Stay updated.